ArticleScientific reports2025
Femtogram-level VEGF detection via PEG-directed gold nanostructured electrochemical immunosensor.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a novel electrochemical immunosensor designed for the highly sensitive detection of vascular endothelial growth factor (VEGF). The sensor utilizes gold nanostructures grown on fluorine-doped tin oxide (FTO) electrodes through a polyethylene glycol (PEG)-mediated electrochemical process. Fabrication involves a two-step immobilization strategy, combining physical vapor deposition (PVD) of a gold thin film with thermal annealing. The nanostructured electrode is subsequently modified electrochemically via PEG mediation, followed by antibody functionalization to enhance binding specificity. PEG-mediated control over nanostructure growth yields irregular short nanorods and leaf-like dendrites, significantly enhancing sensor performance. Extensive electrochemical analyses, including cyclic voltammetry and impedance spectroscopy, confirm improved sensitivity and stability. The optimized immunosensor achieves an ultralow detection limit of 6 fg/mL (corresponding to ~ 9500 VEGF molecules in 60 µL, and a broad linear detection range of 10 fg/mL to 10⁵ fg/mL, with excellent reproducibility. Given VEGF's pivotal role in angiogenesis and tumor progression, this ultrasensitive platform offers a promising tool for early cancer diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.